The Canada MRI Market was valued at $531.20 Mn in 2023 and is predicted to grow at a CAGR of 6.5% from 2023 to 2030, to $825.48 Mn by 2030. The key drivers of this industry include rising prevalence of chronic diseases, technological advancements, and increasing government expenditure. The key players in the industry are Siemens Healthineers, Neusoft, Hitachi High-Tech Corporation, and GE Healthcare among others.
The Canada MRI Market is at around $531.20 Mn in 2023 and is projected to reach $825.48 Mn in 2030, exhibiting a CAGR of 6.5% during the forecast period.
Magnetic resonance imaging (MRI) is a type of diagnostic test that can create detailed images of nearly every structure and organ inside the body. It uses strong magnetic fields and radio waves to produce detailed images of the inside of the body. The MRI machine is a large, cylindrical (tube-shaped) device that generates a powerful magnetic field around the patient and emits pulses of radio waves from a scanner. Some MRI machines resemble narrow tunnels, while others are more spacious. The intense magnetic field produced by the MRI scanner causes the atoms in your body to align in the same direction. Subsequently, radio waves are emitted from the MRI machine, which disrupts this alignment, causing the atoms to return to their original positions. As the radio waves cease, the atoms revert to their initial alignment and emit radio signals. These signals are then picked up by a computer, which transforms them into an image of the area being examined. This image is displayed on a viewing monitor.
Among member countries of the OECD, Canada has 10.05 units available per every million of its population. The market therefore is driven by significant factors like the rise in geriatric population, increasing prevalence of chronic diseases, technological advancements in MRI, and growing demand for early and accurate diagnosis. However, high cost, specialized infrastructure and site requirements, and strict regulatory approval restrict the growth of the market.
The leading pharmaceutical companies include GE Healthcare and Hitachi High-Tech Corporation for MRI machines. Toshiba, Inland Imaging, and Hyperfine Inc. are also significant contributors to the MRI market, with continuous research and development activities.
Market Growth Drivers
Technological Advancement: Continuous advancements in MRI technology are improving image quality, reducing scan times, and offering new applications. Features like AI-powered image analysis and lower-field MRI systems are making MRI more efficient, accessible, and patient-friendly, leading to wider adoption.
Growing Prevalence of Chronic Diseases: The growing prevalence of diseases such as cancer, heart diseases, and disorders of the bones and muscles in Canada is boosting the need for MRI scans for identification and oversight. Cancer remains the top reason for fatalities, making up approximately 25% of all fatalities. The significant impact of these health issues is pushing the need for MRI scans for early detection, diagnosis, and tracking of treatment effects.
Focus on Early Detection: The growing emphasis on early disease detection further fuels the MRI market. Early and accurate diagnosis allows for timely intervention. Canadian healthcare providers are increasingly utilizing MRI technology's detailed scans for faster diagnoses, leading to better patient outcomes and driving market growth.
Market Restraints
High Cost: The significant capital and operational expenditures related to MRI equipment can have a considerable impact on market growth due to budgetary constraints, affordability issues, and accessibility challenges for healthcare providers and patients. These elevated costs impede the adoption and utilization of these advanced imaging technologies.
Competition from Alternative Imaging Modalities: Other medical imaging techniques like CT scans, ultrasound, and PET scans can be more cost-effective alternatives to MRI in certain applications. This competition from substitute products can limit the growth of the MRI market in Canada.
Shortage of Skilled Professionals: The shortage of qualified radiologists and MRI technicians in Canada is a critical factor impeding the growth of the MRI market. The lack of skilled personnel to operate and maintain these advanced imaging systems is limiting the adoption and utilization of MRI services, especially in rural and underserved areas of the country. This deficiency in trained professionals is obstructing access to MRI scans and hindering the expansion of MRI services nationwide.
All MRI machines sold in Canada require approval from Health Canada, the federal department responsible for ensuring the safety, efficacy, and quality of medical devices. Manufacturers must submit detailed documentation demonstrating the device meets Canadian standards. The Canadian Association of Radiologists (CAR) has established guidelines for the safe use of MRI, including standards for MRI facilities, staff training, and patient screening.
Canada has a universal public health insurance system called Medicare that provides coverage for medically necessary hospital and physician services, including MRI scans. Reimbursement rates for MRI scans can differ across provinces, impacting provider revenue and potentially influencing where MRI machines are installed. For example, provinces like Ontario provide more comprehensive coverage for MRI services, while others have more restrictive policies.
Key Players
Here are some of the major key players in the Canada MRI Market:
1. Executive Summary
1.1 Device Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Regulatory Landscape for Medical Device
1.6 Health Insurance Coverage in Country
1.7 Type of Medical Device
1.8 Recent Developments in the Country
2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)
3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints
4. Competitive Landscape
4.1 Major Market Share
4.2 Key Company Profile (Check all Companies in the Summary Section)
4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)
5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment
6. Methodology and Scope
By Architecture
By Field Strength
By Application
By End-User
Methodology for Database Creation
Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.
Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.
How Do We Get It?
Our database is created and maintained through a combination of secondary and primary research methodologies.
1. Secondary Research
With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:
With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:
2. Primary Research
To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:
Combining Secondary and Primary Research
By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:
Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.
We value your inquiry and offer free customization with every report to fulfil your exact research needs.